We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Duke University & Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership

News   Nov 12, 2009

 
Duke University & Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership
 
 
 

RELATED ARTICLES

Time to Say Goodbye… to the “House-hold Measure” BMI?

News

A new study published in PLOS Biology sees an international collaboration of academia and industry experts introduce a novel "revolutionary" approach towards personalized and precision biomedicine, moving away from the "classic" morphometric BMI.

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

Fungus Chemistry May Mimic Opioids With Fewer Side Effects

News

The hunt for an opioid alternative has made a leap forward – a unique fungus may be able to mimic opioid suggesting it could be a safer less addictive drug, helping address the opioid epidemic of deaths by overdose.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE